Quality of life and survival outcomes of patients with inoperable esophageal squamous cell carcinoma after definitive radiation therapy: A multicenter retrospective observational study in China from 2015 to 2016

Zheng, 2022, Cancer incidence and mortality in China, 2016, J Natl Cancer Cent, 2, 1, 10.1016/j.jncc.2022.02.002 Liang, 2017, Epidemiology, etiology, and prevention of esophageal squamous cell carcinoma in China, Cancer Biol Med, 14, 33, 10.20892/j.issn.2095-3941.2016.0093 van Hagen, 2012, Preoperative chemoradiotherapy for esophageal or junctional cancer, N Engl J Med, 366, 2074, 10.1056/NEJMoa1112088 Yang, 2018, Neoadjuvant chemoradiotherapy followed by surgery versus surgery alone for locally advanced squamous cell carcinoma of the esophagus (NEOCRTEC5010): a phase III multicenter, randomized, open-label clinical trial, J Clin Oncol, 36, 2796, 10.1200/JCO.2018.79.1483 Chen, 2019, Comparing paclitaxel plus fluorouracil versus cisplatin plus fluorouracil in chemoradiotherapy for locally advanced esophageal squamous cell cancer: a randomized, multicenter, phase III clinical trial, J Clin Oncol, 37, 1695, 10.1200/JCO.18.02122 Zhang, 2020, Survey on the basic information of personnel and facilities of radiotherapy in Chinese mainland in 2019, China Cancer, 29, 321 Cooper, 1999, Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group, JAMA, 281, 1623, 10.1001/jama.281.17.1623 Ren, 2018, Retrospective analysis of safety profile of high-dose concurrent chemoradiotherapy for patients with oesophageal squamous cell carcinoma, Radiother Oncol, 129, 293, 10.1016/j.radonc.2018.09.006 Yin, 1980, Clinical analysis of radiotherapy for 3798 cases of esophageal carcinoma, Chin J Oncol, 2, 216 Yang, 1992, 10 years results of radiotherapy on 1160 cases of esophageal cancer, Chin J Radiat Oncol, 1, 174 Kumekawa, 2006, Late toxicity in complete response cases after definitive chemoradiotherapy for esophageal squamous cell carcinoma, J Gastroenterol, 41, 425, 10.1007/s00535-006-1771-8 Gillham, 2008, Quality of life and survival in patients treated with radical chemoradiation alone for oesophageal cancer, Clin Oncol (R Coll Radiol), 20, 227, 10.1016/j.clon.2007.12.002 Morota, 2009, Late toxicity after definitive concurrent chemoradiotherapy for thoracic esophageal carcinoma, Int J Radiat Oncol Biol Phys, 75, 122, 10.1016/j.ijrobp.2008.10.075 Chen, 2009, Prevalence of depression and its related factors among Chinese women with breast cancer, Acta Oncol, 48, 1128, 10.3109/02841860903188650 Berhili, 2017, Associated factors with psychological distress in Moroccan breast cancer patients: a cross-sectional study, Breast, 31, 26, 10.1016/j.breast.2016.10.015 DiMatteo, 2000, Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence, Arch Intern Med, 160, 2101, 10.1001/archinte.160.14.2101 Cella, 1993, The functional assessment of cancer therapy scale: development and validation of the general measure, J Clin Oncol, 11, 570, 10.1200/JCO.1993.11.3.570 Darling, 2006, Validation of the functional assessment of cancer therapy esophageal cancer subscale, Cancer, 107, 854, 10.1002/cncr.22055 Fang, 2016 Wang, 2021, Morbidity and mortality of patients who underwent minimally invasive esophagectomy after neoadjuvant chemoradiotherapy vs neoadjuvant chemotherapy for locally advanced esophageal squamous cell carcinoma: a randomized clinical trial, JAMA Surg, 156, 444, 10.1001/jamasurg.2021.0133 Xiao, 2004, Assessment of tumor dose distribution in three dimensional conformal radiotherapy treatment planning system for esophageal cancer, Chin J Radiat Oncol, 13, 273 Lan, 2020, Propensity score-based comparison of survival and radiation pneumonitis after definitive chemoradiation for esophageal cancer: intensity-modulated radiotherapy versus three-dimensional conformal radiotherapy, Radiother Oncol, 149, 228, 10.1016/j.radonc.2020.05.036 Xi, 2017, Comparative outcomes after definitive chemoradiotherapy using proton beam therapy bersus intensity modulated radiation therapy for esophageal cancer: a retrospective, single-institutional analysis, Int J Radiat Oncol Biol Phys, 99, 667, 10.1016/j.ijrobp.2017.06.2450 Ji, 2021, Efficacy of concurrent chemoradiotherapy with S-1vs radiotherapy alone for older patients with esophageal cancer: a multicenter randomized phase 3 clinical trial, JAMA Oncol, 7, 1459, 10.1001/jamaoncol.2021.2705 Liu, 2021, Induction chemotherapy followed by definitive chemoradiotherapy versus chemoradiotherapy alone in esophageal squamous cell carcinoma: a randomized phase II trial, Nat Commun, 12, 4014, 10.1038/s41467-021-24288-1 Shapiro, 2015, Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial, Lancet Oncol, 16, 1090, 10.1016/S1470-2045(15)00040-6 Bailey, 2003, Outcomes after esophagectomy: a ten-year prospective cohort, Ann Thorac Surg, 75, 217, 10.1016/S0003-4975(02)04368-0 Donohoe, 2011, Long-term health-related quality of life for disease-free esophageal cancer patients, World J Surg, 35, 1853, 10.1007/s00268-011-1123-6 Derogar, 2012, Influence of major postoperative complications on health-related quality of life among long-term survivors of esophageal cancer surgery, J Clin Oncol, 30, 1615, 10.1200/JCO.2011.40.3568 Avery, 2007, Quality of life during potentially curative treatment for locally advanced oesophageal cancer, Br J Surg, 94, 1369, 10.1002/bjs.5888 Ariga, 2009, Prospective comparison of surgery alone and chemoradiotherapy with selective surgery in resectable squamous cell carcinoma of the esophagus, Int J Radiat Oncol Biol Phys, 75, 348, 10.1016/j.ijrobp.2009.02.086 Conroy, 2014, Definitive chemoradiotherapy with FOLFOX versus fluorouracil and cisplatin in patients with oesophageal cancer (PRODIGE5/ACCORD17): final results of a randomised, phase 2/3 trial, Lancet Oncol, 15, 305, 10.1016/S1470-2045(14)70028-2 Crosby, 2013, Chemoradiotherapy with or without cetuximab in patients with oesophageal cancer (SCOPE1): a multicentre, phase 2/3 randomised trial, Lancet Oncol, 14, 627, 10.1016/S1470-2045(13)70136-0 Rees, 2015, Patient-reported outcomes during and after definitive chemoradiotherapy for oesophageal cancer, Br J Cancer, 113, 603, 10.1038/bjc.2015.258 Qian, 2022, Definitive chemoradiotherapy versus neoadjuvant chemoradiotherapy followed by surgery in patients with locally advanced esophageal squamous cell carcinoma who achieved clinical complete response when induction chemoradiation finished: a phase II random, Radiother Oncol, 174, 1, 10.1016/j.radonc.2022.06.015 Noordman, 2018, Neoadjuvant chemoradiotherapy plus surgery versus active surveillance for oesophageal cancer: a stepped-wedge cluster randomised trial, BMC Cancer, 18, 142, 10.1186/s12885-018-4034-1